Workup for 30-Year-Old with Hypertension
For a 30-year-old with hypertension, you must confirm the diagnosis with out-of-office BP monitoring, perform targeted screening for secondary causes (which are more common in young-onset hypertension), assess for target organ damage, and evaluate cardiovascular risk using the PREVENT calculator. 1, 2, 3
Diagnostic Confirmation
First, confirm sustained hypertension using out-of-office measurements (home BP monitoring or ambulatory BP monitoring), as office readings alone are insufficient for diagnosis 2. Hypertension is confirmed when BP is ≥140/90 mmHg on repeated measurements, though treatment thresholds may be lower based on risk stratification 1.
Essential Initial Workup
Laboratory Tests
Obtain the following baseline studies:
- Urinalysis with urine albumin-to-creatinine ratio (UACR) - screens for kidney damage and proteinuria 1
- Serum creatinine and estimated GFR - assesses renal function
- Serum potassium - screens for primary aldosteronism (hypokalemia is a red flag)
- Fasting glucose and lipid panel - evaluates metabolic risk factors
- Complete blood count - baseline hematologic assessment
- Electrocardiogram (ECG) - detects left ventricular hypertrophy and cardiac abnormalities 2, 4
Consider Echocardiography
Echocardiography may be useful in young patients to assess for left ventricular hypertrophy and subclinical cardiac damage, particularly when guiding treatment decisions in those with lower estimated CVD risk 1.
Screening for Secondary Hypertension
Young-onset hypertension (age <40 years) has a higher prevalence of secondary causes than hypertension in older adults, making specialist evaluation and targeted screening essential 3.
Key Clinical Red Flags Requiring Further Investigation:
- Hypokalemia (even if mild) → screen for primary aldosteronism
- Abdominal bruit → evaluate for renovascular disease
- Delayed or absent femoral pulses, BP differential between arms → consider coarctation of the aorta
- Episodic symptoms (headaches, palpitations, sweating) → screen for pheochromocytoma
- Family history of early-onset hypertension or kidney disease → consider genetic causes
- Resistant hypertension (uncontrolled on 3+ medications) → broaden secondary cause workup
Recommended Secondary Cause Screening:
The 2025 AHA/ACC guidelines emphasize broader screening for primary aldosteronism in young patients 1. Consider:
- Plasma aldosterone-to-renin ratio - particularly if hypokalemia present or resistant hypertension
- Renal artery imaging (CT angiography, MR angiography, or duplex ultrasound) - if clinical suspicion for renovascular disease
- 24-hour urine metanephrines or plasma metanephrines - if pheochromocytoma suspected
- Renal ultrasound - evaluates kidney size and structure
Cardiovascular Risk Assessment
Use the PREVENT equations (race-free) to calculate 10-year CVD risk 1. This is critical because:
- If 10-year CVD risk ≥7.5%: Initiate pharmacologic therapy at BP ≥130/80 mmHg
- If 10-year CVD risk <7.5%: Start with lifestyle modifications for 3-6 months; if BP remains ≥130/80 mmHg, then initiate pharmacologic therapy 1
For patients <30 years, risk models have limitations. Consider 30-year PREVENT risk estimation or additional risk markers (echocardiography, biomarkers like BNP or high-sensitivity troponin) to guide shared decision-making 1.
Target Organ Damage Assessment
Evaluate for hypertension-related complications:
- Cardiac: ECG for LVH, consider echocardiography for structural assessment
- Renal: Creatinine, eGFR, UACR (microalbuminuria indicates early kidney damage)
- Vascular: Fundoscopic examination for hypertensive retinopathy (though often deferred in primary care)
- Neurologic: History of stroke or TIA
Common Pitfalls to Avoid
- Don't rely solely on office BP measurements - white coat hypertension is common in young patients; confirm with home or ambulatory monitoring 2
- Don't miss secondary causes - the younger the patient, the higher the likelihood of a curable cause 3
- Don't forget to check potassium - even mild hypokalemia warrants aldosteronism screening
- Don't delay specialist referral - guidelines recommend hypertension specialist review for young-onset hypertension to optimize workup and exclude secondary causes 3
Treatment Initiation Framework
Once diagnosis is confirmed and workup complete:
- Stage 2 hypertension (≥140/90 mmHg): Start combination therapy immediately (RAS blocker + CCB or diuretic), preferably as single-pill combination 2
- Stage 1 hypertension (130-139/80-89 mmHg): Base treatment on CVD risk and response to lifestyle modification 1
- Target BP <130/80 mmHg for most patients; consider <120/80 mmHg in selected high-risk individuals 1